BYSI (BeyondSpring) Marketable Securities : $5.96 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. BeyondSpring's Marketable Securities for the quarter that ended in Jun. 2024 was $5.96 Mil.

BeyondSpring's annual Marketable Securities declined from Dec. 2021 ($30.74 Mil) to Dec. 2022 ($2.87 Mil) and declined from Dec. 2022 ($2.87 Mil) to Dec. 2023 ($0.19 Mil).

BeyondSpring Marketable Securities Historical Data

The historical data trend for BeyondSpring's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Marketable Securities Chart

BeyondSpring Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

30.74

2.87

0.19

BeyondSpring Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Marketable Securities	Get a 7-Day Free Trial														21.20	2.87	1.90	0.19	5.96

BeyondSpring Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

BeyondSpring (NAS:BYSI) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

BeyondSpring Marketable Securities Related Terms

Thank you for viewing the detailed overview of BeyondSpring's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

BeyondSpring Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, New Jersey, NJ, USA, 07932

Website

https://www.beyondspringpharma.com

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.